Leadership

Leadership Team Comprises Expertise Necessary to Develop Products & Company

cm-new

Christopher Marshall PhD, President & CEO

Founded three biotechs, is an inventor and former strategy consultant.

Dirk

Dirk Pleimes, MD, CMO

Founded four biotechs and worked in clinical development in large pharma. Expert in respiratory-inflammatory disease.

team-my-new

Mark Yondola, PhD, CSO

Established Calder’s bioprocess technology. Expert in vaccine design, protein chemistry and virology.

Susan-small copy

Susan Stella, MBA, Interim COO

Expert strategist with emerging tech & life science companies as well as investors.

Scientific Advisory Board

team-buckland

Barry Buckland, PhD

Merck Vaccines, VP Manufacturing for 16 years. Manufactured a large number of approved vaccine products.

Visit BiologicB

florian-new-blue

Florian Schödel, MD

Merck Vaccines, VP Clinical Research for 8 years. Directed clinical studies for licensure of multiple approved vaccines.

Visit Philimmune

team-mclellan

Jason S. McLellan, PhD

Univ. of Texas. Pre-eminent in vaccine design. Most Covid-19 vaccines programs based on Jason’s 2P-design.

Visit McLellan Lab | Visit AAAS

team-hoffman

Alexander Hoffmann, PhD

UCLA. Pre-eminent in the field of innate immunity (adjuvants); Director, Instit. for Quant. & Computational Biosciences.

Visit UCLA

 

Key Personnel

team-4-blue

Devarshi Brahmbhatt, MS

Expert in downstream process development.

team-1-blue

Sonal Gidwani, MS

Expert in crosslinking chemistry and controls; analytical development.

Collaborating Scientists

barney-large

Barney Graham, MD, PhD

Deputy Director, Vaccine Research Center, NIAID/NIH
Collaborator in RSV immunogen design.

Visit AAAS

team-jc

James E. Crowe, Jr., MD

Director, Vanderbilt Vaccine Center, VUMC; IDBiologics
Collaborator in universal flu immunogen design.

Visit AAAS

team-ke

Kerry Empey, PharmD, PhD

Assoc. Professor, Dept. Pharmacy and Therapeutics
Collaborator in adjuvant selection for maternal RSV vaccine.

Bonnie

Bonnie Blomberg, PhD

Prof. of Microbiology and Immunology, Univ. of Miami
Collaborator in adjuvant selection for RSV vaccine for the elderly.

Daniela

Daniela Frasca, PhD

Res. Asst. Prof of Microbiol. & Immunol., Univ. of Miami
Collaborator in adjuvant selection for RSV vaccine for the elderly

Experts-In-Residence

team-bertuccioli

Claudio Bertuccioli, PhD

Advising on financing strategies. Biotech VC for 15 years.

Heidi

Heidi Agostini, PhD

Consulting on govt. funding strategies. Obtained & executed $200M-$7B BARDA/DoD/NIH contracts.

James

James E. Hough, JD

Consulting on communications and strategy; partner at Morrison & Foerster LLP for 25+ years